ArticleMolecular and clinical oncology2018

Cell cycle checkpoint control: The cyclin G1/Mdm2/p53 axis emerges as a strategic target for broad-spectrum cancer gene therapy - A review of molecular mechanisms for oncologists.

Erlinda M Gordon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.